首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >Evaluation of the anti-atherogenic potential of chrysin in Wistar rats
【24h】

Evaluation of the anti-atherogenic potential of chrysin in Wistar rats

机译:菊花蛋白对Wistar大鼠抗动脉粥样硬化的潜力评估

获取原文
获取原文并翻译 | 示例
           

摘要

Hypercholesterolemia is one of the major risk factors that precipitate coronary heart disease and atherosclerosis. Oxidative stress is believed to contribute to the pathogenesis of hypercholesterolemic atherosclerosis; hence, various antioxidant compounds are being evaluated for potential anti-atherogenic effects. In the present study, the putative anti-atherogenic and antioxidant efficacy of a flavonoid, chrysin, was evaluated in an experimental model of atherosclerosis. In male, albino Wistar rats fed an atherogenic diet for 45 days and treated with saline, significantly higher mean levels of serum lipid profile parameters (total cholesterol, triglycerides, low-density, and very low-density lipoprotein cholesterol), lower mean levels of high-density lipoprotein cholesterol and higher mean serum levels of hepatic marker enzymes (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and lactate dehydrogenase) were observed when compared with the levels in rats fed a control diet. In addition, significantly lower mean hepatic levels of lipoprotein lipase, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, antioxidant enzymes (catalase, superoxide dismutase, and glutathione peroxidase) and non-enzymatic antioxidants (reduced glutathione, and vitamins C and E), and a significantly higher mean level of hepatic malondialdehyde (MDA) were noted in comparison to the values in control rats. In atherogenic diet-fed rats that received chrysin orally (200 mg/kg b.wt) for 15 days, starting 30 days after the start of the atherogenic diet, significantly lower mean serum levels of lipid profile parameters (except for HDL-cholesterol which was elevated), hepatic marker enzymes, and significantly higher mean hepatic levels of LPL, HMG-CoA reductase, enzymatic, and non-enzymatic antioxidants and significantly lower mean levels of hepatic MDA were noted, compared to the values in atherogenic diet-fed, saline-treated rats. Histopathological studies appeared to suggest the protective effect of chrysin on the hepatic tissue and aorta of atherosclerotic rats. These results suggest that chrysin has anti-atherogenic potential in an experimental setting.
机译:高胆固醇血症是导致冠心病和动脉粥样硬化的主要危险因素之一。氧化应激被认为是高胆固醇血症性动脉粥样硬化的发病机理。因此,正在评估各种抗氧化剂化合物的潜在抗动脉粥样硬化作用。在本研究中,在动脉粥样硬化的实验模型中评估了类黄酮(Chrysin)的假定抗动脉粥样硬化和抗氧化功效。在雄性白化病Wistar大鼠中,连续45天进食了致动脉粥样硬化饮食,并用生理盐水处理后,其血清脂质谱参数(总胆固醇,甘油三酸酯,低密度和极低密度脂蛋白胆固醇)的平均水平明显升高,而与饲喂对照饮食的大鼠相比,观察到高密度脂蛋白胆固醇和较高的血清平均肝标志物酶水平(天冬氨酸氨基转移酶,丙氨酸氨基转移酶,碱性磷酸酶和乳酸脱氢酶)。此外,脂蛋白脂肪酶,3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶,抗氧化酶(过氧化氢酶,超氧化物歧化酶和谷胱甘肽过氧化物酶)和非酶促抗氧化剂(还原型谷胱甘肽,与维生素C和E)相比,与对照组大鼠相比,肝丙二醛(MDA)的平均水平明显更高。在开始致动脉粥样化饮食后30天开始口服chrysin(200 mg / kg b.wt)15天的致动脉粥样化饮食喂养的大鼠中,平均血清脂质水平参数水平显着降低(HDL-胆固醇除外与肝动脉性饮食喂养的值相比,肝标志物酶和LPL,HMG-CoA还原酶,酶和非酶抗氧化剂的平均肝水平明显升高,肝MDA的平均水平显着降低,盐水处理的大鼠。组织病理学研究似乎表明,菊花素对动脉粥样硬化大鼠的肝组织和主动脉具有保护作用。这些结果表明,在实验环境中,菊花素具有抗动脉粥样硬化的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号